Friday, March 29, 2019

What's the Future of Weed? Cannabis Industry Leaders Share at SXSW Panel


Because the cannabis industry and landscape changes at a rapid pace, many have predictions about the next big thing in weed. That doesn't mean we'll have the flying car of dispensaries anytime soon, but weed-trimming robots are right around the corner.

At South by Southwest (SXSW) 2019's inaugural cannabis business tract, the evolution of cannabis retailers and dispensaries was one of the hottest topics of discussion. The trajectory was the focus of “Dispensaries of the Future,” a 60-minute panel featuring four experts: Chelsea Bernardo and Ashley Picillo of Point Seven Group, a global cannabis retail consultant agency that has served more than 100 clients; Anne Forkutza, vice president of strategic programs at Cova, a cannabis software company; and Megan Stone of High Road Studio, which has been consulting on branding and interior design for dispensaries for five years.



Given that SXSW is a general music/film/tech conference located in Austin, Texas, a state where legalization still has plenty of hurdles, the intended audience was broad and themes were aimed largely at entrepreneurs and customers entering the cannabis marketplace for the first time.
The broader theme embraced by each of the panelists was that in the early days of cannabis legalization, the product sold itself. Now with an estimated 4,000 dispensaries in the U.S., according to the panelists, competing for customer loyalty in a landscape where consumers already have plenty of options presents a new set of challenges and demands a new style of dispensary.

Here are the four biggest takeaways from the panel:
1. Retailers Are Coming to Main Street
“People don't want [dispensaries] in their backyard, because the images they associate with this business are those bad, negative, grimy, grungy, illegal black market type spaces,” Stone explained to give context as to many dispensary owners have previously been “relegated to awful parts of town and build out in spaces that were never meant to be retail spaces.” These locations have been seen as less-than-inviting to new consumers to cannabis, who may still feel as though buying cannabis is an illicit activity.
But that's starting to change. MedMen opened a retailer on Fifth Avenue in Manhattan, New York, and Planet 13 is just off of the Las Vegas Strip. Stone and her company consulted Maitri Medicinals in Uniontown, Pennsylvania, a cannabis retailer in a 10,000-square-foot space in the heart of the downtown Historic District. A boutique hotel can be seen through 14-foot-(4.27 meter)-high glass windows that are designed to invite walk-in traffic and prepare consumers for a comfortable shopping experience.
“We put cannabis on Main Street to present a completely different image than anybody had ever thought,” Stone said.
2. Retailers Need to Tell a Story
“When you think about a local restaurant or coffee shop you go to, why do you like it? You like it because of the staff, you know the owner, you know why they started that coffee shop in the first place. That's very similar [to] creating a brand for a dispensary,” Forkutza said.
Most restaurants build their identity on the origin story of their founders or chefs, a strategy that works equally well for dispensaries. Highlighting a founder's community activism and history in the industry goes a long way to establish brand loyalty. Colorado's 3D Cannabis Centers in Salida and Denver serve as an excellent example of brand-building, based on founder Toni Savage Fox's two decades of marijuana advocacy —and holding the distinction of selling the very first recreational sale in the world.

It's also becoming much harder to distinguish your brand based on the product alone, whereas as a dispensary owner your background can set you apart.
“When you move into different dispensaries, we're seeing a lot of commonality in terms of what is available on store shelves,” Bernardo said. “All things equal, we need to think about how to draw people in when your offering is pretty much the same.”
3. Brand Your Shop After a Familiar Retail Experience
When you can't touch or sample the product a store is selling, it's tough to make a connection with customers. Retail consumers typically think of items behind glass as luxury goods like jewelry, which appeal to aspirational desires. There are few experiences quite like visiting a dispensary, which once again turns off first-time customers.

Much like a welcoming lobby, creating a familiar experience encourages walk-ins as well as those intimidated by typical dispensaries. One example of a dispensary taking a different brand identity approach is Prairie Records in Canada. The Warman, Saskatchewan, dispensary models its layout like a record shop, with shelves full of faux LPs listing strains and their effects. It adds a more tactile element to a shopping experience in which shoppers can't just walk up and touch the products. And most importantly, it gives people a touch point of a familiar type of business to lower the barriesr to exploration.
“It's a way to erase 80 years of negative stigma. You have to get over that hurdle and giving them something they can relate to is hugely important,” Stone said.
4. Retail Operations Need to be on Point
Dressing up a dispensary like a record store won't become the norm, but staying current with the cutting edge of retail logistics is one way for a dispensary to distinguish itself. Technological advances are key but also a challenge, given that cannabis shops are one of the only types of retail stores that accept only cash.

“Providing a space where [a woman is] comfortable to set down a purse, or providing privacy so that a woman can take her wallet out, [which is] the most vulnerable thing you will ever do in a retail space as a woman, [so they can] start shelling out hundred dollar bills,” Stone said.
Especially in medical dispensaries, the checkout process is much more complicated than just scanning a barcode. Forkutza cited the statistic that customers typically wait between 3 and 5 minutes at checkout, a flow experience that's uncommon in most other retail businesses.

Streamlining that experience requires a point of sale system that allows maximum efficiency. “You don't want to buy a point of sale system that doesn't have an open platform,” Forkutza said. That means software that fluidly incorporates online ordering, a mobile app, digital menu boards, and potentially even vending machines with facial recognition.
“I think the way that the federal government wants to treat this and evolve on banking, taxation, and interstate commerce will be the wildcard factors in Whole Foods selling weed someday, as opposed to this golden ticket license that people have fought so hard for,” Stone said.

Source: Original article is posted on https://news.weedmaps.com/2019/03/whats-the-future-of-weed-cannabis-industry-leaders-share-at-sxsw-panel/

Monday, March 18, 2019

Medical Marijuana Doctors Online Suggest Incorporating Cannabis As A Part Of Your Wellness Care

Enter 2019.

New year parties, new work goals, and those new year resolutions.

They come every year, but nothing goes the way it is supposed to be.

But, what if we tell you, this year you can actually include cannabis into your wellness plans!

Excited!

Well sure, you will be. After all, it is cannabis what we are talking about in here.

So, let’s get started with the medical marijuana healthcare and wellness program. But, hey! Before starting anything concerning cannabis, you must have an mmj card by the certified medical marijuana doctors online or else new year might turn into legal disasters.

Medical Cannabis and Endocannabinoid System


Like, the body contains different systems for managing different functions of the body. Similarly, to manage a range of functions such as mood, immunity, appetite, balancing, and others, another system has been discovered which is popularly known as the endocannabinoid system.


 The system contains a network of receptors which are present in almost every part of the body. Therefore, if there is pressure on you for eating healthy, sleeping more, losing weight, including physical activity, staying calm, and whatnot.

Uggh! Too much pressure already!

Stop the pressure building in your brain, and get started with the cannabis trends and other related things starting today.

Cannabis For A Good Night Sleep

See, whenever we are out of sleep, or there is something going on which makes sleeping difficult, it encourages you to eat processed foods for those late night cravings.
This usually affects all the efforts that you put during the day. Plus, no sleep means no gymming the next day. So, if you want to add health to your daily routine, start using cannabis in your diet plans and see the transformations. Also, it is a well-known sedative, so a good night sleep will always be around the corner.
Cannabis For Care

Well everyone loves sports in one form or the other. And injuries with sports are no surprises. Its but obvious if your play, injuries are bound to happen. But, what if we tell you injuries can be fun too with cannabis.

Medical cannabis has anti-inflammatory effects which can help anyone recover from any type of sports injuries. Topical cream and lotions are a good option. It is recommended to use jojoba oil base that allows the cannabinoids to penetrate into the skin more easily.

Cannabis Medication Tips

  • Keep a journal such as Gold Leaf that will help you understand the strains, products, and their effects so you can better understand what works for you.
  • Know about the terpene content and understand what will be beneficial for your body type.
  • Medical marijuana doctors online suggest going for flower in forms in which you prefer the most. Make sure that it has been extracted in the most gentle way possible. Especially, because it preserves all the benefits that plant has to offer.
 The health and wellness industry concerning cannabis is growing rapidly as well as evolving because of its amazing potential as a therapeutic aid. But, you will require a cannabis card or get your cannabis card renewal before its expiry to access products for your wellness and care.

Wednesday, March 6, 2019

What is medical marijuana?

The term medical marijuana refers to using the whole, unprocessed marijuana plant or its basic extracts to treat symptoms of illness and other conditions. The U.S. Food and Drug Administration (FDA) has not recognized or approved the marijuana plant as medicine.




Image Source: @shutterstock.com/g/Atomazul


However, scientific study of the chemicals in marijuana, called cannabinoids, has led to two FDA-approved medications that contain cannabinoid chemicals in pill form. Continued research may lead to more medications.
Because the marijuana plant contains chemicals that may help treat a range of illnesses and symptoms, many people argue that it should be legal for medical purposes. In fact, a growing number of states have legalized marijuana for medical use.

Why isn’t the marijuana plant an FDA-approved medicine?

The FDA requires carefully conducted studies (clinical trials) in hundreds to thousands of human subjects to determine the benefits and risks of a possible medication. So far, researchers haven't conducted enough large-scale clinical trials that show that the benefits of the marijuana plant (as opposed to its cannabinoid ingredients) outweigh its risks in patients it's meant to treat.
Read more about the various physical, mental, and behavioral effects of marijuana in our Marijuana DrugFacts.

Can Medical Marijuana Legalization Decrease Prescription Opioid Problems?

Some studies have suggested that medical marijuana legalization might be associated with decreased prescription opioid use and overdose deaths, but researchers don't have enough evidence yet to confirm this finding. For example, one study found that Medicare Part D prescriptions filled for all opioids decreased in states with medical marijuana laws.1 Another study examined Medicaid prescription data and found that medical marijuana laws and adult-use marijuana laws were associated with lower opioid prescribing rates (5.88 percent and 6.88 percent lower, respectively).2
Additionally, one NIDA-funded study suggested a link between medical marijuana legalization and fewer overdose deaths from prescription opioids.3 These studies, however, are population-based and can’t show that medical marijuana legalization caused the decrease in deaths or that pain patients changed their drug-taking behavior.4,5 A more detailed NIDA-funded analysis showed that legally protected medical marijuana dispensaries, not just medical marijuana laws, were also associated with a decrease in the following:6
  • opioid prescribing
  • self-reports of opioid misuse
  • treatment admissions for opioid addiction
Additionally, some data suggests that medical marijuana treatment may reduce the opioid dose prescribed for pain patients,7,8 while another recent NIH-funded study suggests that cannabis use appears to increase the risk of developing and opioid use disorder.9 NIDA is funding additional studies to determine the link between medical marijuana use and the use or misuse of opioids for specific types of pain, and also its possible role for treatment of opioid use disorder. Read more in our Marijuana Research Report.

What are cannabinoids?

Cannabinoids are chemicals related to delta-9-tetrahydrocannabinol (THC), marijuana’s main mind-altering ingredient that makes people "high." The marijuana plant contains more than 100 cannabinoids. Scientists as well as illegal manufacturers have produced many cannabinoids in the lab. Some of these cannabinoids are extremely powerful and have led to serious health effects when misused. Read more in our Synthetic Cannabinoids (K2/Spice) DrugFacts.
The body also produces its own cannabinoid chemicals. They play a role in regulating pleasure, memory, thinking, concentration, body movement, awareness of time, appetite, pain, and the senses (taste, touch, smell, hearing, and sight).

How might cannabinoids be useful as medicine?

Currently, the two main cannabinoids from the marijuana plant that are of medical interest are THC and CBD. 
THC can increase appetite and reduce nausea. THC may also decrease pain, inflammation (swelling and redness), and muscle control problems.Unlike THC, CBD is a cannabinoid that doesn't make people "high." These drugs aren't popular for recreational use because they aren't intoxicating. It may be useful in reducing pain and inflammation, controlling epileptic seizures, and possibly even treating mental illness and addictions. Many researchers, including those funded by the National Institutes of Health (NIH), are continuing to explore the possible uses of THC, CBD, and other cannabinoids for medical treatment.
For instance, recent animal studies have shown that marijuana extracts may help kill certain cancer cells and reduce the size of others. Evidence from one cell culture study with rodents suggests that purified extracts from whole-plant marijuana can slow the growth of cancer cells from one of the most serious types of brain tumors. Research in mice showed that treatment with purified extracts of THC and CBD, when used with radiation, increased the cancer-killing effects of the radiation.10

                              Image Source: @shutterstock.com/g/AlexRaths
Scientists are also conducting preclinical and clinical trials with marijuana and its extracts to treat symptoms of illness and other conditions, such as:
  • diseases that affect the immune system, including:
    • HIV/AIDS
    • multiple sclerosis (MS), which causes gradual loss of muscle control
  • inflammation
  • pain
  • seizures
  • substance use disorders
  • mental disorders
Read more about the NIH’s marijuana research:

Using Medical Marijuana During and After Pregnancy

Some women report using marijuana to treat severe nausea they have during pregnancy. But there's no research that shows that this practice is safe, and doctors generally don't recommend it. 
Pregnant women shouldn't use medical marijuana without first checking with their health care provider. Animal studies have shown that moderate amounts of THC given to pregnant or nursing women could have long-lasting effects on the child, including abnormal patterns of social interactions11 and learning issues.12,13 Read more in our Substance Use in Women Research Report.

What medications contain cannabinoids?

Two FDA-approved drugs, dronabinol and nabilone, contain THC. They treat nausea caused by chemotherapy and increase appetite in patients with extreme weight loss caused by AIDS. Continued research might lead to more medications. 
The FDA approved a CBD-based liquid medication called Epidiolex® for the treatment of two forms of severe childhood epilepsy, Dravet syndrome and Lennox-Gastaut syndrome
The United Kingdom, Canada, and several European countries have approved nabiximols (Sativex®), a mouth spray containing THC and CBD. It treats muscle control problems caused by MS, but it isn't FDA-approved.

Points to Remember

  • The term medical marijuana refers to treating symptoms of illness and other conditions with the whole, unprocessed marijuana plant or its basic extracts.
  • The FDA has not recognized or approved the marijuana plant as medicine.
  • However, scientific study of the chemicals in marijuana called cannabinoids has led to two FDA-approved medications in pill form, dronabinol and nabilone, used to treat nausea and boost appetite.
  • Cannabinoids are chemicals related to delta-9-tetrahydrocannabinol (THC), marijuana’s main mind-altering ingredient.
  • Currently, the two main cannabinoids from the marijuana plant that are of interest for medical treatment are THC and cannabidiol (CBD).
  • The body also produces its own cannabinoid chemicals.
  • Scientists are conducting preclinical and clinical trials with marijuana and its extracts to treat symptoms of illness and other conditions.

References

  1. Bradford AC, Bradford D, Abraham AJ, Bagwell Adams G. Association Between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population. JAMA Intern Med. April 2018. doi:10.1001/jamainternmed.2018.0266
  2. Wen H, Hockenberry J. Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees. JAMA Intern Med.doi:10.1001/jamainternmed.2018.1007
  3. Bachhuber MA, Saloner B, Cunningham CO, Barry CL. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. JAMA Intern Med. 2014;174(10):1668-1673. doi:10.1001/jamainternmed.2014.4005.
  4. Finney JW, Humphreys K, Harris AHS. What ecologic analyses cannot tell us about medical marijuana legalization and opioid pain medication mortality. JAMA Intern Med. 2015;175(4):655-656. doi:10.1001/jamainternmed.2014.8006.
  5. Bachhuber MA, Saloner B, Barry CL. What ecologic analyses cannot tell us about medical marijuana legalization and opioid pain medication mortality--reply. JAMA Intern Med. 2015;175(4):656-657. doi:10.1001/jamainternmed.2014.8027.
  6. Powell D, Pacula RL, Jacobson M. Do Medical Marijuana Laws Reduce Addiction and Deaths Related to Pain Killers?RAND Corporation; 2015. https://www.rand.org/pubs/external_publications/EP67480.html. Accessed April 6, 2017.
  7. Abrams DI, Couey P, Shade SB, Kelly ME, Benowitz NL. Cannabinoid-opioid interaction in chronic pain. Clin Pharmacol Ther. 2011;90(6):844-851. doi:10.1038/clpt.2011.188.
  8. Lynch ME, Clark AJ. Cannabis reduces opioid dose in the treatment of chronic non-cancer pain. J Pain Symptom Manage. 2003;25(6):496-498.
  9. Olfson M, Wall MM, Liu S-M, Blanco C. Cannabis Use and Risk of Prescription Opioid Use Disorder in the United States. Am J Psychiatry. 2017;175(1):47-53. doi:10.1176/appi.ajp.2017.17040413
  10. Scott KA, Dalgleish AG, Liu WM. The combination of cannabidiol and Δ9-tetrahydrocannabinol enhances the anticancer effects of radiation in an orthotopic murine glioma model. Mol Cancer Ther. 2014;13(12):2955-2967. doi:10.1158/1535-7163.MCT-14-0402.
  11. Trezza V, Campolongo P, Cassano T, et al. Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in Wistar rats. Psychopharmacology (Berl). 2008;198(4):529-537. doi:10.1007/s00213-008-1162-3.
  12. Antonelli T, Tomasini MC, Tattoli M, et al. Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring. Cereb Cortex N Y N 1991. 2005;15(12):2013-2020. doi:10.1093/cercor/bhi076.
  13. Mereu G, Fà M, Ferraro L, et al. Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release. Proc Natl Acad Sci U S A. 2003;100(8):4915-4920. doi:10.1073/pnas.0537849100.